Search research articles
Contact Us
Filters
Showing results (131-140 of 145) with videos related to
Page
of 15
Sort By:
Investigational New Drugs
|
June 10, 2017
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials
Jean-Marie Michot, Lina Benajiba, Laura Faivre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial
Susanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
Plos One
|
December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer
Yann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2021
Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction
Matthieu Faron, Armel Maurice Cheugoua-Zanetsie, Pierre Thirion, et al.
Science Translational Medicine
|
July 11, 2014
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, et al.
The Lancet. Oncology
|
July 3, 2021
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research
Priya Ranganathan, Girish Chinnaswamy, Manju Sengar, et al.
JAMA Network Open
|
December 6, 2024
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers
Nicholas Bird, Nicole Scobie, Pablo Berlanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2020
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy
Nicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 145) with videos related to
Sort By:
Page
of 15
Investigational New Drugs
|
June 10, 2017
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials
Jean-Marie Michot, Lina Benajiba, Laura Faivre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial
Susanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
Plos One
|
December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer
Yann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2021
Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction
Matthieu Faron, Armel Maurice Cheugoua-Zanetsie, Pierre Thirion, et al.
Science Translational Medicine
|
July 11, 2014
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, et al.
The Lancet. Oncology
|
July 3, 2021
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research
Priya Ranganathan, Girish Chinnaswamy, Manju Sengar, et al.
JAMA Network Open
|
December 6, 2024
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers
Nicholas Bird, Nicole Scobie, Pablo Berlanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2020
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy
Nicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
Page
of 15